Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Poster Title
Home
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
P
130
PBPK Model Development & Simulations to Predict Drug-Drug Interactions of Atogepant
Favorite
025
Pediatric Drug Development Programs for Locally Acting Drug-Device Combination Products
Favorite
123
Pharmacogenomics of β-lactam Antibiotic-induced Severe Cutaneous Adverse Reactions
Favorite
012
Pharmacogenomics of L-Asparaginase-induced Pancreatitis in Pediatric Patients With Acute Lymphoblastic Leukemia
Favorite
173
Pharmacokinetic & Pharmacodynamic Modeling of QY201, a JAK1/TYK2 Inhibitor, in Healthy Chinese Adults
Favorite
031
Pharmacokinetic Drug Interaction Between Nipocalimab & Fremanezumab in Healthy Subjects
Favorite
059
Pharmacokinetics & Immunogenicity of Combination Therapy of Guselkumab & Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis
Favorite
124
Pharmacokinetics & Pharmacodynamics of Casirivimab & Imdevimab in Pregnant Outpatients With COVID-19
Favorite
125
Pharmacokinetics & Pharmacodynamics of Casirivimab &Imdevimab in Pediatric Outpatients With COVID-19
Favorite
083
Pharmacokinetics & Safety of Navitoclax in Hepatic Impairment
Favorite
183
Pharmacokinetics & Viral Shedding of an Oncolytic Virus (MEDI5395) in a Phase 1 Clinical Study
Favorite
022
Pharmacokinetics of a Fixed-dose Combination of Dapagliflozin 10 mg & Sitagliptin 100 mg for the Treatment of Type 2 Diabetes Mellitus
Favorite
189
Pharmacokinetics of Cemiplimab in Patients With Advanced Non-Small Cell Lung Cancer
Favorite
182
Pharmacokinetics of RBN-3143 in Healthy Adults, A Novel Mono (ADP-Ribose) Polymerase-14 (PARP14) Inhibitor
Favorite
065
Pharmacokinetics of Subcutaneous Itepekimab Injection With an Autoinjector Device or Prefilled Syringe
Favorite
076
Pharmacokinetics, Metabolism, Excretion & Mass Balance of 14C-HZN-825, a LPAR-1 Antagonist, in Healthy Male Subjects
Favorite
167
Pharmacokinetics, Pharmacodynamics & Exposure- Response for Neurotoxicity Adverse Events in a Phase Ib/II CARTITUDE-1 Open-Label Study
Favorite
071
Pharmacokinetics, Safety & Tolerability of HZN-825, a LPAR-1 Antagonist, Following Single & Multiple Doses in Healthy Japanese Subjects
Favorite
179
Phase 1 Study Evaluating the Bioequivalence of the Dispersible Final Market Image Macitentan Tablet & the Opsumit® Tablet in Fasted Conditions
Favorite
148
PK/PD Modeling of Progranulin Elevation in Blood & CSF to Support AL101 Dose Selection & Phase 2 Study Design
Favorite
048
Population Modeling Analyses of Sotatercept Pharmacokinetics, Safety & Efficacy in Healthy Participants & Patients With Pulmonary Arterial Hypertension
Favorite
056
Population Pharmacokinetic Analysis of Tucatinib in Healthy Subjects & Subjects With HER2+ Metastatic Breast Cancer or Metastatic Colorectal Cancer
Favorite
057
Population Pharmacokinetic Model Development of Autologous CD30.CAR-T Cells in Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) Patients
Favorite
069
Population Pharmacokinetic Model of Delta-9-Tetrahydrocannabinol (THC) & Metabolites in Healthy Adults Following Single Oral Dose
Favorite
186
Population Pharmacokinetic Modeling of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Solid Tumors
Favorite
055
Population Pharmacokinetic Modeling to Assess the Impacts of Clinical Variables on Mycophenolate Total Body Clearance in Pediatric Kidney Transplant Recipients
Favorite
047
Population Pharmacokinetic Modeling to Establish Exposure Equivalence Between Two Formulations of Albuterol Dry Powder Inhaler
Favorite
184
Population Pharmacokinetic Modelling of RP-6306, a Novel PKMYT1 Inhibitor, in Cancer Patients from a Phase 1 Dose Escalation Study
Favorite
072
Population Pharmacokinetic Modelling to Confirm Weight-Based Banded Dosing & Exposure-Response Efficacy Analyses to Support Trofinetide Treatment in Rett Syndrome
Favorite
058
Population Pharmacokinetic Modelling to Predict Trofinetide Exposure & Exposure-Response Safety Analyses in Girls With Rett Syndrome Aged 2–4 Years
Favorite
168
Population Pharmacokinetic/Pharmacodynamic Analysis of MDM2 Inhibitor Navtemadlin (KRT-232) in Combination with Decitabine in a Phase 1 Dose Escalation Study of Subjects With Acute Myeloid Leukemia
Favorite
142
Population Pharmacokinetic-Pharmacodynamic (PKPD) Modeling Analyses of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Solid Tumors
Favorite
066
Population Pharmacokinetics & Exposure-Response Analysis of Durvalumab With Gemcitabine & Cisplatin in Patients With Advanced Biliary Tract Cancer
Favorite
075
Precision Dosing in Critically Ill Patients: A Voriconazole Case Study
Favorite
041
Predicting Clinical PK/PD & Impacts of Organ Impairment to Support Clinical Development of siRNA-based Therapeutics Using a Mechanistic Physiologically Based Pharmacokinetic & Pharmacodynamic (PBPK-PD) Platform Model
Favorite
110
Predicting Pregnancy Population Pharmacokinetics Using Machine Learning Algorithms
Favorite
196
Predictive Physiologically Based Pharmacokinetic (PBPK) Model Suggests Minimal Drug-Drug Interaction (DDI) Between PPARδ Agonist Mavodelpar (REN001) & Rosuvastatin
Favorite
128
Probing CYP3A4 Drug Metabolism Change in Patients With Obesity Undergoing Weight-Loss Using a Micro-Dose of Midazolam
Favorite
086
Probing Gastric Emptying & Drug Metabolism Changes in Patients With Obesity Undergoing Weight-Loss Using a Cocktail Containing Acetaminophen, Caffeine & Omeprazole
Favorite
153
Proof of Mechanism & Pharmacodynamic Fingerprinting; Relating 7,000 Protein Measurements to Disease & Pharmacology: An Example Using the Impact of Peginterferon on Influenza A Pathway
Favorite
195
Protamine Protects Against Vancomycin Induced Kidney Injury in a Translational Rat Model
Favorite